Delivery Order SPE2DB24D2010-SPE2DB25FABCA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram quantities, with a ceiling value of $4,473.45. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Pimecrolimus...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,887.66 to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 30-gram units. This firm fixed price, non-competitive delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram units, with a ceiling value of $10,804.84 and an ultimate completion date of May 2, 2025. This is a firm fixed-price delivery order under a non-set-aside competitive procurement, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply action supporting...
- The Defense Logistics Agency (DLA) awarded a $2,458.75 delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in 100-gram units, with an ultimate completion date of September 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in a 30-gram quantity, valued at $20,510.86. This delivery order, issued on September 11, 2025, represents a firm fixed-price contract with an ultimate completion date of September 12, 2025. The contract carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 2, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram units, with a ceiling value of $1,484.50. This firm fixed-price delivery order, with an ultimate completion date of July 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation....
- The Defense Logistics Agency awarded a $2,637.47 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Pimecrolimus 1% cream. As the prime contractor, Amerisourcebergen will supply 100 grams of the prescribed topical cream to fulfill requirements under the contract. Performance will occur at Amerisourcebergen's Conshohocken, Pennsylvania facility by August 4, 2023. The Defense Logistics Agency leverages contracts such as this to efficiently procure medical supplies in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Pimecrolimus 1% Cream in 100-gram units. This contract, valued at $3,265.16, represents a firm fixed-price delivery order with an ultimate completion date of August 11, 2025. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $244,960 delivery order to Amerisourcebergen Drug Corporation for Pimecrolimus 1% cream. The firm fixed price order is for 30 grams of the topical cream to support Defense Department dermatological needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from June 21st to June 22nd, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the...
- The Defense Logistics Agency awarded a $316 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pimecrolimus 1% cream. The single day order is for 100 grams of the topical immunosuppressant cream to support Defense Department health programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring pharmaceuticals and medical...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FABCADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,031.34 to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in 100-gram quantities. This non-competitive delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed-price procurement executed under a child contract mechanism. The contractor, headquartered in Conshohocken, Pennsylvania, performed this order from its corporate office location. Pimecrolimus is a topical immunomodulator commonly used in dermatological applications, particularly for treating inflammatory skin conditions, supporting the Defense Logistics Agency's mission to supply pharmaceutical products for military healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor agreement enables the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates consistent capability in fulfilling diverse medical procurement requirements across multiple therapeutic domains, with awards structured as firm fixed-price delivery orders ranging from minimal to substantial values, positioning the company as a critical vendor within the Defense Logistics Agency's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/5/25 |